Wikidata

(Q63335648)

English

Investigation of the Safety, Tolerability and Potential Therapeutic Effects of JNJ-40411813 in Patients With Schizophrenia

clinical trial

In more languages

Statements

title
First-in-Patient Study to Assess the Safety and Tolerability and to Explore the Potential Therapeutic Efficacy of a Novel Glutamate Modulator as Monotherapy and as Add-On Therapy in Patients With Schizophrenia (English)
0 references
country
Austria
0 references
Belgium
0 references
Bulgaria
0 references
Germany
0 references
Romania
0 references
Spain
0 references
start time
May 2011
0 references
end time
November 2012
0 references
number of participants
100
0 references
minimum age
18 year
0 references
maximum age
65 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63335648&oldid=1857152843"